dr.

(Marieke) HM Krol

Profile

Marieke Krol has a Bachelor's degree in nursing from The Hague University of Professional Education and a Master's degree in Health Economics, obtained at the Erasmus University Rotterdam. Since 2006, she has been working as a researcher at institute for Medical Technology Assessment (iMTA). Marieke's research mainly focuses on methodological issues of health economics (involving issues on costs as well as effects of health care interventions). She is working on a PhD dissertation on methodological aspects of productivity cost identification, measurement and valuation. Marieke is furthermore active in teaching in the Health Economics and Health Economics, Policy and Law master program. She is coordinator of the Health Technology Assessment course in the master programs.

• All publications (23)

  • Article (21)

    • H.M. Krol, A. Nap, R. Michels, C. Veraart & L.M.A. Goossens (2019). Health state utilities for infertility and subfertility. Reproductive Health. doi: 10.1186/s12978-019-0706-9
    • A.E. Attema, H.M. Krol, N.J.A. van Exel & W.B.F. Brouwer (2018). New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year. European Journal of Health Economics (HEPAC), 19 (2), 277-291. doi: 10.1007/s10198-017-0883-9
    • K. Hubens, A.M.M. Arons & H.M. Krol (2018). Measurement and evaluation of quality of life and well-being in individuals having or having had fertility problems: a systematic review. European Journal of Contraception and Reproductive Health Care. doi: 10.1080/13625187.2018.1539161
    • H.M. Krol, J. Papenburg, S.S. Tan, W.B.F. Brouwer & L. Hakkaart-van Roijen (2016). A Noticeable Difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs. European Journal of Health Economics (HEPAC), 17 (4), 391-402. doi: 10.1007/s10198-015-0685-x
    • C.J. Tilling, H.M. Krol, A.E. Attema, A. Tsuchiya, J. Brazier, N.J.A. van Exel & W.B.F. Brouwer (2016). Exploring a new method for deriving the monetary value of a QALY. European Journal of Health Economics (HEPAC), 17 (7), 801-809. doi: 10.1007/s10198-015-0722-9
    • H.M. Krol, A.E. Attema, N.J.A. van Exel & W.B.F. Brouwer (2016). Altruistic preferences in TTO: Consideration of effects on others in health state valuations. Medical Decision Making, 36 (2), 187-198. doi: 10.1177/0272989X15615870
    • H.M. Krol, J. Papenburg & N.J.A. van Exel (2015). Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. Pharmacoeconomics (Print), 33 (2), 123-135. doi: 10.1007/s40273-014-0218-y
    • H.M. Krol & W.B.F. Brouwer (2015). Unpaid work in economic evaluations. Social Science & Medicine, 144, 127-137. doi: 10.1016/j.socscimed.2015.09.008
    • C.A.M. Boumans, H.M. Krol, J.L. Severens, M.A. Koopmanschap, W.B.F. Brouwer & L. Hakkaart-van Roijen (2015). The iMTA Productivity Cost Questionnaire A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses. Value in Health, 18, 753-758. doi: 10.1016/j.jval.2015.05.009
    • E. Vermaire, H.M. Krol, W.B.F. Brouwer & C. van Loveren (2014). Value for money: economic evaluation of two different caries prevention programmes compared with standard care in a randomized controlled trial. Caries Research, 48 (3), 244-253. doi: 10.1159/000356859
    • H.M. Krol, E.A. Stolk & W.B.F. Brouwer (2014). Predicting productivity based on EQ-5D: an explorative study. The European Journal Of Health Economics, 15 (5), 465-475. doi: 10.1007/s10198-013-0487-y
    • H.M. Krol, W.B.F. Brouwer & F.F.H. Rutten (2013). Productivity costs in economic evaluations: past, present, future. Pharmacoeconomics (Print), 31 (7), 537-549. doi: 10.1007/s40273-013-0056-3
    • H.M. Krol, W.B.F. Brouwer, J.L. Severens, J. Kaper & S.M.A.A. Evers (2012). Productivity cost calculations in health economic evaluations: Correcting for compensation mechanisms and multiplier effects. Social Science & Medicine, 75, 1981-1988. doi: 10.1016/j.socscimed.2012.07.012
    • C.J. Tilling, H.M. Krol, A. Tsuchiya, J. Brazier, N.J.A. van Exel & W.B.F. Brouwer (2012). Does the EQ-5D Reflect Lost Earnings? Pharmacoeconomics (Print), 1 (30), 47-61. doi: 10.2165/11539910-000000000-00000
    • E. Heintz, H.M. Krol & L.A. Levin (2012). The Impact of Patients' Subjective Life Expectancy on Time Tradeoff Valuations. Medical Decision Making. doi: 10.1177/0272989X12465673
    • H.M. Krol, J. Papenburg, M.A. Koopmanschap & W.B.F. Brouwer (2011). Do Productivity Costs Matter? Pharmacoeconomics (Print), 7, 601-619.
    • C.J. Tilling, H.M. Krol, A. Tsuchiya, J. Brazier & W.B.F. Brouwer (2010). In or Out? Income Losses in Health State Valuations: A Review. Value in Health, 13 (2), 298-305. doi: 10.1111/j.1524-4733.2009.00614.x
    • H.M. Krol, P. Sendi & W.B.F. Brouwer (2009). Breaking the Silence: Exploring the Potential Effects of Explicit Instructions on Incorporating Income and Leisure in TTO Exercices. Value in Health, 12 (1), 172-180. doi: 10.1111/j.1524-4733.2008.00406.x
    • L. Scalone, L.G. Mantovani, H.M. Krol, D. Rofail, S. Ravera, H.F.L. Garretsen, C. Borgna-Pignatti, L. Borsellino, P. Cianciulli, L. Prossomariti, I. Stefano, M.D. Cappellini (2008). Costs, quality of life, treatment satisfaction and compliance in patients with B-thalassemia major undergoing iron chelation therapy: the ITHACA study. Current Medical Research & Opinion, 24 (7), 1905-1917. doi: 10.1185/03007990802160834
    • H.M. Krol, M.I. Koopman & C.A. de Uyl-de Groot (2007). A systematic review of economic analyses of pharmaceutical therapies for advanced colorectal cancer. Expert Opinion on Pharmacotherapy, 8, 1313-1328. doi: 10.1517/14656566.8.9.1313
    • H.M. Krol, W.B.F. Brouwer & P. Sendi (2006). Productivity Costs in Health -State Valuations. Pharmacoeconomics (Print), 24, 401-414.

  • Report (1)

    • R. Riemsma, M.J. Al, I. Corro Ramos, S.N. Deshpande, N. Armstrong, Y.C. Lee, S. Ryder, C. Noake, H.M. Krol, M. Oppe, J. Kleijnen & J.L. Severens (2013). SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis. (Extern rapport). Southampton: National Institute for Health Research doi: 10.3310/hta17610

  • Doctoral thesis (1)

    • H.M. Krol (2012, december 21). Productivity costs in economic evaluations. EUR (268 pag.) (Rotterdam: Optima Grafische Communicatie) Prom./coprom.: prof.dr. W.B.F. Brouwer.

• Present position

  (external) researcher

  University

  Erasmus University Rotterdam

  School

  Erasmus School of Health Policy & Management

  Department

  Health Technology Assessment (HTA)

  Country

  The Netherlands

  Telephone

  0621307891